Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

Part of paid clinical trials in Charlotte, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT07175376
Status
Recruiting

Conditions

  • Cancer
  • Chemotherapy
  • Frail

Eligibility Criteria

Sex
ALL
Age
65 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Supportive Care — OTHER
    Geriatric assessment (GA) -guided supportive care and weekly Patient Reported Outcomes (PRO) symptom assessment

Study Details

The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.

Key Dates

Start date
Mar 16, 2026
Status verified
Jan 2026
Primary completion
Jan 31, 2027
Completion
May 31, 2027

Study Design

Enrollment
32 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Participants 65 years or older with active cancer diagnosis and planned chemotherapy
    Participants aged 65 or older with an active cancer diagnosis who are planned to receive chemotherapy and are eFI pre-frail or frail. Participants will be provided with results and education regarding baseline assessments and offered referrals for supportive care interventions to decrease chemotherapy toxicity

Primary Outcome Measure

Recruitment rate [ Time Frame: Enrollment ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Levine Cancer InstituteCharlotteNorth Carolina28204
Kunal Kadakia, MD
980-442-5905
Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-SalemNorth Carolina27157
James Morgan
336-702-4491
Heidi Klepin, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Charlotte, NC

Related Studies